INOZYME PHARMA INC

CUSIP: 45790W108 Class: Common Stock

Pivotal bioVenture Partners Investment Advisor LLC's Holding History (CIK: 0001844645)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 4,494,851 Value ($000) $17,979 Avg Close — Range —
Q1 2025
Shares 4,494,851 Value ($000) $4,090 Avg Close — Range —
Q4 2024
Shares 4,494,851 Value ($000) $12,451 Avg Close — Range —
Q3 2024
Shares 4,494,851 Value ($000) $23,508 Avg Close — Range —
Q2 2024
Shares 4,494,851 Value ($000) $20,047 Avg Close — Range —
Q1 2024
Shares 4,494,851 Value ($000) $34,431 Avg Close — Range —
Q4 2023
Shares 4,494,851 Value ($000) $19,148 Avg Close — Range —
Q3 2023
Shares 4,494,851 Value ($000) $18,878 Avg Close — Range —
Q2 2023
Shares 3,661,518 Value ($000) $20,395 Avg Close — Range —
Q1 2023
Shares 3,213,586 Value ($000) $18,414 Avg Close — Range —
Q4 2022
Shares 2,661,154 Value ($000) $2,794 Avg Close — Range —
Q3 2022
Shares 2,661,154 Value ($000) $7,132 Avg Close — Range —
Q2 2022
Shares 2,661,154 Value ($000) $12,694 Avg Close — Range —
Q1 2022
Shares 1,591,154 Value ($000) $6,508 Avg Close — Range —
Q4 2021
Shares 1,591,154 Value ($000) $10,852 Avg Close — Range —
Q3 2021
Shares 1,591,154 Value ($000) $18,441 Avg Close — Range —
Q2 2021
Shares 1,591,154 Value ($000) $27,113 Avg Close — Range —
Q1 2021
Shares 1,591,154 Value ($000) $31,505 Avg Close — Range —
Q4 2020
Shares 1,591,154 Value ($000) $32,841 Avg Close — Range —